XML 50 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Shareholders' Equity (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Assumptions Used in the Weighted Average Fair Value of the Stock Options Granted
The weighted average fair value of the Company’s stock options granted during 2020, 2019 and 2018 were $13.53, $13.94 and $13.04, respectively, using the following assumptions:
202020192018
Expected term (in years)5.795.536.34
Expected volatility29.02 %23.36 %25.27 %
Expected dividend yield1.29 %1.10 %1.35 %
Risk-free interest rate0.62 %1.80 %2.75 %
Schedule of Stock-based Compensation Expense
The Company recognized stock-based compensation expense in its Consolidated Financial Statements in 2020, 2019 and 2018 as follows:
202020192018
Stock-based compensation expense$27,014 $24,582 $23,805 
Less: Deferred tax benefit(5,182)(4,814)(5,078)
Stock-based compensation expense, net of tax$21,832 $19,768 $18,727 
Schedule of Stock Option Plans
This table presents certain information relating to the Company’s stock option plans for 2020, 2019 and 2018:
Number of
Shares
Weighted
Average Price
Balance as of December 31, 201716,712,000 $37.63 
Granted2,468,000 49.94 
Exercised(3,232,000)25.93 
Expired or canceled(135,000)49.58 
Balance as of December 31, 201815,813,000 $41.84 
Granted2,480,000 64.04 
Exercised(2,243,000)25.27 
Expired or canceled(344,000)55.07 
Balance as of December 31, 201915,706,000 $47.43 
Granted4,529,000 56.54 
Exercised(1,563,000)28.83 
Expired or canceled(177,000)55.76 
Balance as of December 31, 202018,495,000 $51.15 
Exercisable as of December 31, 20206,641,000 $39.35 
Available for future grant as of December 31, 202015,287,000 
Schedule of Stock Options Outstanding and Exercisable
This table summarizes information relating to all options outstanding and exercisable at December 31, 2020:
 Options Outstanding at December 31, 2020Options Exercisable at December 31, 2020
Range of Exercise Prices (Per Share)Number of SharesWeighted Average
Exercise Price
(Per Share)
Weighted Average
Remaining
Contractual
Life (Years)
Number of SharesWeighted Average
Exercise Price
(Per Share)
Weighted Average
Remaining
Contractual
Life (Years)
$15.77 -$21.05 665,000 $15.79 0.95665,000 $15.79 0.95
22.45 -23.86 944,000 22.45 1.95944,000 22.45 1.95
27.03 -40.64 2,699,000 37.35 3.491,857,000 35.85 3.29
45.99 -56.60 8,398,000 62.57 8.093,170,000 51.34 5.53
57.48 -71.12 5,789,000 49.76 8.085,000 63.50 6.82
18,495,000 6,641,000 
Schedule of Common Stock Buyback The following table provides the total number of shares repurchased and the related total costs in 2020, 2019 and 2018:
YearTotal Number of
Shares Repurchased
Total Cost
20208,008,000 $424,702 
20196,225,000 348,348 
20186,744,000 404,759